Australia markets closed

Nuvectis Pharma, Inc. (NVCT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.70-0.02 (-0.30%)
As of 03:19PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3333
Avg. Estimate-0.4-0.38-1.52-1.78
Low estimate-0.4-0.4-1.59-2.07
High estimate-0.39-0.36-1.49-1.51
Year ago EPS-0.27-0.38-1.43-1.52
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3333
Avg. EstimateN/AN/AN/A23.06M
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/A69.19M
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.44-0.29-0.34-0.36
Actual EPS-0.27-0.38-0.37-0.41
Difference0.17-0.09-0.03-0.05
Surprise %38.60%-31.00%-8.80%-13.90%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.4-0.38-1.52-1.78
7 days ago-0.4-0.38-1.52-1.78
30 days ago-0.4-0.38-1.54-1.63
60 days ago-0.37-0.36-1.46-1.54
90 days ago-0.37-0.36-1.46-1.54
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/A1N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesNVCTIndustrySector(s)S&P 500
Current qtr.-48.10%N/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year-6.30%N/AN/AN/A
Next year-17.10%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A